Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Eckelt

Andreas Eckelt, Odenthal DE

Patent application numberDescriptionPublished
20120003643ENRICHMENT AND IDENTIFICATION OF FETAL CELLS IN MATERNAL BLOOD AND LIGANDS FOR SUCH USE - The present invention relates to enrichment and/or identification of fetal cells of a maternal blood sample using fetal cell specific ligands and/or fetal cell specific hybridization probes. Enriched or identified fetal cells may be subjected to steps of detection or diagnosis, wherefore the present invention enables non-invasive prenatal diagnostics.01-05-2012

Gunter Eckelt, Wunstorf DE

Patent application numberDescriptionPublished
20110023702PNEUMATIC CYLINDER - The invention relates to a pneumatic cylinder (02-03-2011

Reinhard Eckelt, Berlin DE

Patent application numberDescriptionPublished
20080249327Catalyst for the Synthesis of Dimethyl Carbonate in the Gas Phase - The invention relates to an improved catalyst for the synthesis of dimethyl carbonate by reacting methanol, carbon monoxide and oxygen in the gas phase and to the use thereof. The catalyst consists of a copper-containing zeolite produced by admixing one or more halide-free copper(II) compounds to a zeolite in a liquid medium, drying the zeolite modified by the admixture, and tempering at 400-900° C. under inert conditions, essentially retaining the crystallinity of the zeolite, said admixing being effected by means of a method selected from the group consisting of impregnation of the zeolite, ion exchange, precipitation of copper(II) hydroxide in the presence of the zeolite, and a combination of these methods. The catalyst shows high space-time yields, is constant over the period of operation and has no corrosive action.10-09-2008

Volker H.o. Eckelt, Jena DE

Patent application numberDescriptionPublished
20090247427LABEL-FREE HIGH THROUGHPUT BIOMOLECULAR SCREENING SYSTEM AND METHOD - A screening system and method are described herein which provide a unique and practical solution for enabling label-free high throughput screening (HTS) to aid in the discovery of new drugs. In one embodiment, the screening system enables direct binding assays to be performed in which a biomolecular interaction of a chemical compound (drug candidate) with a biomolecule (therapeutic target) can be detected using assay volumes and concentrations that are compatible with the current practices of HTS in the pharmaceutical industry. The screening system also enables the detection of bio-chemical interactions that occur in the wells of a microplate which incorporates biosensors and surface chemistry to immobilize the therapeutic target at the surface of the biosensors. The screening system also includes fluid handling and plate handling devices to help perform automated HTS assays.10-01-2009